According to FutureWise analysis the market for cardiac biomarkers testing in 2023 is US$ 13.39 billion, and is expected to reach US$ 31.13 billion by 2031 at a CAGR of 11.10%.
Cardiac biomarkers are protein molecules released into the bloodstream as a result of cardiac injury or stress. These biomarkers could be used to detect cardiovascular diseases such as cardiac ischemia, myocardial infarction, congestive heart failure, and acute coronary syndrome, among others (ACS). Cardiac biomarker testing enable doctors to assess a patient's likelihood of developing such conditions. These tests are carried out if a patient experiences chest pain. Troponin, creatine kinase-muscle/brain (CK-MB), B-type natriuretic peptide (BNP), high-sensitivity C-reactive protein (hs-CRP), and other cardiac biomarkers are commonly evaluated for CVD. Myocardial muscle creatine kinase (CK-MB), troponin I and T, myoglobin, brain natriuretic peptides (BNPs), ischemia modified albumin (IMA), and other cardiac biomarkers are commonly employed as an integrated diagnostic method for cardiovascular diseases (CVDs). In the future years, the market is likely to be driven by an increase in the senior population as well as an increase in the number of patients suffering from heart attacks and chest discomfort as a result of changing lifestyles. Increased funding for cardiac biomarker research from both public and private institutions is also expected to boost market growth in the coming years.
FutureWise Market Research has instantiated a report that provides an intricate analysis of Cardiac Biomarkers Testing Market trends that shall affect the overall market growth. Furthermore, it includes detailed information on the graph of profitability, SWOT analysis, market share and regional proliferation of this business. Moreover, the report offers insights on the current stature of prominent market players in the competitive landscape analysis of this market.
According to the research study conducted by FutureWise research analysts, the Cardiac Biomarkers Testing Market is anticipated to attain substantial growth by the end of the forecast period. The report explains that this business is predicted to register a noteworthy growth rate over the forecast period. This report provides crucial information pertaining to the total valuation that is presently held by this industry and it also lists the segmentation of the market along with the growth opportunities present across this business vertical.